Influence of Beer on Gut Microbiota and Biochemical Outcomes: Alcohol Impact.
NCT ID: NCT03513432
Last Updated: 2019-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-03-26
2019-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Gut Microbiome in the Health Benefits
NCT05300165
Effects of Ethanol on Gut Wall Integrity
NCT02126072
Alcoholic Liver Disease and the Gut Microbiome
NCT05007470
Metabolic Imprints of Alcoholic Beverages
NCT03384147
Evaluation of Bioavailability and Metabolism of Diet Phenolic Compounds
NCT03614520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
The study will focus on the effects of beer on microbiota and biochemical biomarkers in healthy human volunteers.
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beer with 5.20 % alcohol
330 ml beer (5.20 % alcohol)/day
Beer with 5.20 % alcohol
330 ml beer (5.20 % alcohol)/day during 4 weeks
Non-alcoholic beer with 0.45 % alcohol
330 ml non-alcoholic beer (0.45 % alcohol)/day
Non-alcoholic beer with 0.45 % alcohol
330 ml non-alcoholic beer (0.45 % alcohol)/day during 4 weeks
Non-alcoholic beer with 0.00 % alcohol
330 ml non-alcoholic beer (0.00 % alcohol)/day
Non-alcoholic beer with 0.00 % alcohol
330 ml nonalcoholic beer (0.00 % alcohol)/day during 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beer with 5.20 % alcohol
330 ml beer (5.20 % alcohol)/day during 4 weeks
Non-alcoholic beer with 0.45 % alcohol
330 ml non-alcoholic beer (0.45 % alcohol)/day during 4 weeks
Non-alcoholic beer with 0.00 % alcohol
330 ml nonalcoholic beer (0.00 % alcohol)/day during 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy volunteers free of chronic diseases with relevant effect on gastrointestinal system;
* Without a diagnosis of any digestive disease including functional bowel disorders such as IBS;
* Moderate alcohol consumers;
* Willing and able to provide written informed consent.
Exclusion Criteria
* With diabetes or other relevant metabolic diseases;
* With any known infectious diseases, namely infections with HIV, Hepatitis B or C virus;
* Intake of antibiotics in the last 4 weeks and laxatives in the last 2 weeks;
* Subjects with history of drug, alcohol or other substances abuse.
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Nova de Lisboa
OTHER
Universidade do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Conceição Calhau, PhD
Role: PRINCIPAL_INVESTIGATOR
NOVA Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculdade de Ciências Médicas da Universidade NOVA de Lisboa
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MICROAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.